GLP-1 drugs and surprise pregnancies: what the data shows

What did @realdrbae actually say?

The core claim here is that semaglutide and similar GLP-1 drugs slow gastric emptying enough to reduce how much of the oral contraceptive pill (OCP) your body actually absorbs, meaning your pill might not be doing its full job. The creator recommends switching to a backup method, specifically naming the NuvaRing as a safer option. Credit where it's due: they correctly framed this as a risk to be aware of rather than a certainty, and they were clear this is about the pill specifically, not all contraception.

They also correctly noted that non-hormonal methods and abstinence are unaffected by GLP-1 drugs. The recommendation to use a backup method is clinically reasonable. The NuvaRing shoutout, however, is a bit of an odd single-solution pivot when there are several better-studied alternatives worth naming first.

Does the science back this up?

Partially, but with some important caveats. Yes, GLP-1 receptor agonists slow gastric emptying, and this is a real pharmacological concern for any orally absorbed drug. The FDA-approved labeling for semaglutide (Ozempic, Wegovy) does include a warning about this interaction. A 2022 pharmacokinetic study by Hausner et al. published in Clinical Pharmacokinetics found that semaglutide reduced Cmax of oral contraceptive ethinylestradiol by about 12% and levonorgestrel by about 13%, which is statistically meaningful but not dramatic.

What the video glosses over is that Novo Nordisk's own clinical data, reviewed during drug approval, found no clinically meaningful change in contraceptive efficacy based on ovulation suppression markers. That doesn't mean the interaction is zero, but it does mean the evidence for actual pregnancy risk from this specific mechanism is thinner than the video implies. The "everybody's getting pregnant" framing is doing a lot of heavy lifting for a relatively modest pharmacokinetic signal.

What did they get wrong (or right)?

The creator got the mechanism basically right. Delayed gastric emptying is real, and oral drug absorption can be affected. But they probably overstate the clinical magnitude of this risk. Saying "your birth control is not as effective" as a near-certainty goes further than the current evidence actually supports. The Hausner et al. data showed reduced absorption, but the ovulation suppression data from the same trial didn't show a meaningful difference.

The bigger miss is the NuvaRing recommendation. The NuvaRing is a vaginal hormonal ring, so it bypasses oral absorption entirely, which is a legitimate reason to mention it. But IUDs, both hormonal and copper, are tier-one recommendations from most reproductive health guidelines for exactly this kind of situation. Progestin implants are another top-tier option. Recommending the NuvaRing without mentioning IUDs or implants leaves out the most reliable alternatives. The creator also mispronounces semaglutide as "ozemic" repeatedly, which is a minor issue but worth noting if you're taking clinical advice from someone.

What should you actually know?

If you're on a GLP-1 drug and taking oral contraceptives, the honest answer is: the interaction is real but the magnitude of pregnancy risk increase is not well-quantified in humans. The FDA labeling does flag it. ACOG and most gynecologists suggest using a backup method during the first four weeks of GLP-1 treatment or when doses are escalated. That's prudent advice.

The better solutions than the NuvaRing, in terms of evidence and reliability, are long-acting reversible contraceptives: the hormonal IUD, the copper IUD, or a subdermal implant. These are not affected by anything you eat, inject, or absorb because they work locally or systemically without relying on your gut. If you want to stay on a pill, a non-oral route like a patch or ring does avoid the absorption problem, which is the actual logic behind the NuvaRing mention. But your prescriber should be leading this conversation, not a TikTok video.

• Talk to your provider before switching contraception methods.
• If you prefer hormonal contraception, ask about non-oral options like patches, rings, or implants.
• The copper IUD is a highly effective non-hormonal option completely unaffected by GLP-1 drugs.